[At the present level of anticoagulation therapy with Pelentan, is it possible to expect effective prevention of thromboembolism?].
D005017:Ethyl Biscoumacetate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control*
D005017:Ethyl Biscoumacetate
Je mozné pri súcasnej úrovni antikoagulacnej liecby Pelentanom ocakávat úcinnú prevenciu tromboembolických príhod?